Autonomix Medical has entered a warrant inducement agreement with an investor for the immediate exercise of outstanding warrants, raising approximately $2.6 million. The investor will purchase 428,731 shares at a reduced price of $6.00 per share. In return, the company will issue new warrants exercisable at $5.75 per share, valid for five and a half years. This funding supports Autonomix's development of its nerve-targeted medical device technology, with the transaction expected to close around July 15, 2026.
Madonna returned to New York City to celebrate her No.1 album Confessions II with CLUB CONFESSIONS, a nightlife event co-hosted by MISTR that highlights dance music, queer culture, and HIV prevention. The event featured performances by Madonna and co...
Edelson Lechtzin LLP is investigating Richemont for allegedly raising prices on luxury goods due to tariffs imposed under the Trump administration and failing to refund customers after the U.S. Supreme Court ruled those tariffs unlawful in February 2...
A 30 MW Bitcoin mining facility is proposed near Starkville, Mississippi, promising to lower local energy bills by spreading utility costs. The project is still under early review with no approvals yet, and skepticism exists about whether it will tru...
Universal (UVV), a tobacco and plant-based ingredients company, is rated as a 'sell' due to significant operational and financial challenges. Its Ingredients Operations segment struggles with low profitability, high fixed costs, and inventory write-d...
China's trade growth in June far exceeded expectations, with exports rising 27% year-on-year and imports increasing 36%, driven by strong global demand for AI hardware and U.S. retailers rushing shipments ahead of potential tariff hikes. The trade su...
